
Silvergate Pharma’s XATMEP pediatric drug receives FDA approval
DENVER -- Silvergate Pharmaceuticals, Inc. , leaders in development and commercialization of innovative and safe medicines for children, announced that the U.S. Food and Drug Administration... Read More
Thursday April 27, 2017 0 comments

CBSA honors nine leaders at annual awards dinner
DENVER -- Colorado BioScience Association (CBSA) honored nine of the states top bioscience leaders during its annual awards dinner Nov. 3. The event, held at the Omni Interlocken Resort in... Read More
Monday November 7, 2016 0 comments

Silvergate Pharmaceuticals receives FDA approval for Qbrelis to treat children
DENVER -- Silvergate Pharmaceuticals, a leader in the development and commercialization of innovative and safe medicines for children, today announced the U.S. FDA approved Qbrelis (Lisinopril)... Read More
Monday August 1, 2016 0 comments